StockNews.com initiated coverage on shares of Check-Cap (NASDAQ:CHEK – Free Report) in a research note published on Friday morning. The firm issued a sell rating on the medical research company’s stock.
Check-Cap Price Performance
NASDAQ CHEK opened at $1.87 on Friday. Check-Cap has a 1 year low of $1.77 and a 1 year high of $4.63. The stock has a market capitalization of $10.94 million, a PE ratio of -0.59 and a beta of 0.39. The business’s 50-day moving average is $1.95 and its 200 day moving average is $2.13.
Check-Cap Company Profile
Read More
- Five stocks we like better than Check-Cap
- What to Know About Investing in Penny Stocks
- Why Block’s Key Components Make It a Solid Investment Choice
- With Risk Tolerance, One Size Does Not Fit All
- Is Applied Digital’s Stock Set to Surge With NVIDIA’s Backing?
- When to Sell a Stock for Profit or Loss
- 4 Reasons to Consider Adding General Mills to Your Portfolio
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.